AZ, Daiichi ink co-marketing deal on Nexium
AstraZeneca (AZN.L) and Daiichi Sankyo (4568.T) said they have agreed to co-promote and supply the heartburn treatment Nexium in Japan in a deal that includes a $100 million up-front payment to AstraZeneca. Report
Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product
Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.
